Association of < em > CYP3A5*3, CYP3A4*18 & amp; CYP2B6*6 < /em > polymorphisms with imatinib treatment outcome in Azerbaijani chronic myeloid leukaemia patients

CONCLUSIONS: Our results demonstrated that CYP3A4*18 was significantly associated with IM treatment response in patients with CML in Azerbaijan, whereas rather common CYP3A5*3 was identified to have no such association.PMID:37706370 | DOI:10.4103/ijmr.ijmr_1103_22

Source: Indian J Med Res - September 14, 2023 Category: Research Authors: Chingiz Asadov Nigar Karimova Aypara Hasanova Bayram Bayramov Aytan Shirinova Zohra Alimirzoyeva Source Type: research